Related Experiment Video
Updated: Apr 1, 2026
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Sterile Inflammation after Intravitreal Injection of Aflibercept in a Korean Population
Ju Young Kim1, Yong Sung You1, Oh Woong Kwon1
1Nune Eye Hospital, Seoul, Korea.
Purpose:
To report the frequency and clinical features of sterile inflammation after intravitreal aflibercept injection in a Korean population.
Methods:
A single-center, retrospective study was performed in patients who received intravitreal aflibercept from July 2013 through January 2015.
Results:
A total of four cases of post-injection sterile inflammation were identified from 723 aflibercept injections in 233 patients. Patients presented 1 to 13 days after intravitreal aflibercept injection (mean, 5 days). The mean baseline visual acuity was 20 / 60, which decreased to 20 / 112 at diagnosis but ultimately recovered to 20 / 60. Three cases had inflammatory cells in the anterior chamber (mean, 2.25+; range, 0 to 4+), and all cases had vitritis (mean, 3+; range, 2+ to 4+). No patients had pain. Only one patient underwent anterior chamber sampling (culture negative) and injection of antibiotics. Three of four patients were treated with a topical steroid, and all experienced improvement in their symptoms and signs of inflammation.
Conclusions:
The overall incidence of sterile inflammation after intravitreal aflibercept injection in a Korean population was 4 of 723 injections (0.55%), or 4 of 233 patients (1.79%). Sterile inflammation after intravitreal aflibercept injection typically presents without pain, and the visual outcomes are generally favorable.
